TrueTicker

NIFTY 500 › Healthcare

Healthcare · NIFTY 500

NATCO Pharma Ltd.

NATCOPHARM on NSE · 19 Nov 2026

NIFTY 500

821.95 ▲ +0.16 % on the day

Overview Technical Risk & rank Quality Results Accounts Filings Guidance & governance

Balance sheet

What the company owns and owes, as reported.

₹ cr31 Mar 202630 Sep 202531 Mar 202530 Sep 202431 Mar 202430 Sep 2023
Total assets11,07410,4308,6318,2456,9066,254
Equity attributable to owners9,2218,6507,6077,1505,8535,294
Current borrowings606253273201363239
Non-current borrowings10000000
Cash and cash equivalents19910412010570104

Cash flow

Where the cash came from and went, by financial year.

₹ crYear to Mar 2026Year to Mar 2025Year to Mar 2024Year to Mar 2023Year to Mar 2022
Cash flow from operating activities1,7681,6971,21284946
Cash flow from investing activities-2,143-1,414-1,033-477-5
Cash flow from financing activities298-211-247-36335
Purchase of property, plant and equipment388401339146233

Figures are consolidated, in ₹ cr unless the line is a percentage, from the company's results filed with NSE. Companies report a balance sheet twice a year and cash flow for the year to date; a dash means the line was not reported.

Ask Sensei

Ask Sensei

Ask about any NIFTY 500 company in plain words. The answer comes from its own filings, with the page behind every point.

For example:

See a sample answer

Start free Sign in